The UoC shall annually, or within a month of concluding a production cycle, publicly disclose per site: a) the use of any CIA, including the written justification for use under the exceptional circumstances listed in Indicator 4.4.12; and b) the antibiotic load calculated in Indicator 4.4.15.
